Skip to main content
Publish date:

Barr Gets Zyprexa OK

It will sell a generic version.

Barr Pharmaceuticals

(BRL)

got tentative approval from the Food and Drug Administration for its generic version of Zyprexa tablets of 5mg, 10mg, 15mg and 20mg.

The Woodcliff Lake, N.J.-based company expects to receive the final approval following the expiration of the 30-month stay in April 2007.

TheStreet Recommends

Zyprexa is indicated for the treatment of schizophrenia and for the short-term treatment of acute manic episodes associated with bipolar I disorder.

This story was created through a joint venture between TheStreet.com and IRIS.